Built for patient advocacy intelligence
See the Platform in Action
Comprehensive dashboards, detailed scoring, and actionable insights
Patient advocacy landscape
Respiratory launch planning
1,284 organizations · 42 countries · refreshed 2h ago
Organizations
1,284
+38 this week
Avg. readiness
78%
+6 pts
Audit coverage
94%
critical fields
Priority markets
12
EU + US
Market concentration
By organization countTop match
European Lung Foundation
United Kingdom · Respiratory
Strong education footprint, current clinical trial activity, and high-confidence source coverage.
Interactive preview - switch views and scroll inside the screen
Strategic Intelligence Suite
Everything you need to identify, evaluate, and partner with patient advocacy groups
Multi-Dimensional Scoring
Proprietary v5.0 algorithm assessing governance, research impact, patient reach, and pharma readiness.
Automated Discovery
Scanning 500+ global data sources and registries to ensure no emerging group is missed.
Executive Reporting
Board-ready PDF exports generated in under 2 minutes with AI-powered insights.
Relationship Mapping
Explore organization networks, therapeutic focus areas, and known stakeholder connections in one view.
Source Audit Trails
Review where key fields came from, with confidence signals and source coverage for critical profile data.
Refreshable Intelligence
Keep profiles and reports current as new source data is collected, reviewed, and added to the platform.
From Data to Decision in Three Steps
Connect & Discover
We continuously ingest data from public registries, annual reports, social media, and organizational websites.
AI Analysis
Our scoring engine evaluates each organization across 40+ dimensions including governance, reach, and research capability.
Strategic Output
You receive scored, ranked organizations with AI-generated commentary and partnership recommendations.
Ready to transform your PAG strategy?
Join pharmaceutical companies already using our platform to identify and partner with patient advocacy groups.